Article
Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test.
Molecular genetics & genomic medicine - 1 Dec 2022
Jingxin Shan, Shitong Cheng
Abstract excerpt
BACKGROUND: This study was to reveal the prevalence of definite familial hypercholesterolemia (FH) in the hospital-visiting population, determine the pathogenic mutation detection rate in clinically diagnosed definite FH patients, and expand the FH mutation spectrum in China. METHODS: Blood lipid profiles of 41,803 patients visiting the hospital were investigated and 4967 patients with clinical diagnoses of other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
